1. Shafi, Saba, Jones, Dan, Iwenofu, O Hans, Satturwar, Swati. 2023. Novel ATG7::RAF1 gene fusion in malignant glomus tumor. In Genes, chromosomes & cancer, 63, e23202. doi:10.1002/gcc.23202. https://pubmed.ncbi.nlm.nih.gov/37724934/
2. Zhang, Jinghui, Wu, Gang, Miller, Claudia P, Baker, Suzanne J, Ellison, David W. 2013. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. In Nature genetics, 45, 602-12. doi:10.1038/ng.2611. https://pubmed.ncbi.nlm.nih.gov/23583981/
3. Nakama, Kenta, Ogata, Dai, Nakano, Eiji, Takahashi, Akira, Yamazaki, Naoya. 2021. Clinical response to a MEK inhibitor in a patient with metastatic melanoma harboring an RAF1 gene rearrangement detected by cancer gene panel testing. In The Journal of dermatology, 48, e256-e257. doi:10.1111/1346-8138.15849. https://pubmed.ncbi.nlm.nih.gov/33768587/
4. Wu, Yao, Jia, Qunying, Tang, Qi, He, Yingchun, Tang, Faqing. 2024. A specific super-enhancer actuated by berberine regulates EGFR-mediated RAS-RAF1-MEK1/2-ERK1/2 pathway to induce nasopharyngeal carcinoma autophagy. In Cellular & molecular biology letters, 29, 92. doi:10.1186/s11658-024-00607-4. https://pubmed.ncbi.nlm.nih.gov/38943090/
5. Ko, Jung Min, Kim, Jae-Min, Kim, Gu-Hwan, Yoo, Han-Wook. 2008. PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome. In Journal of human genetics, 53, 999-1006. doi:10.1007/s10038-008-0343-6. https://pubmed.ncbi.nlm.nih.gov/19020799/